Efficacy of Local Infiltration of Tranexamic Acid and Lidocaine in Tonsillar Bed on Postoperative Bleeding and Pain During Tonsillectomy Surgery: Prospective, Randomized, Control Study
1 other identifier
interventional
94
1 country
1
Brief Summary
All anesthetic techniques aim to lessen intra-operative surgical site bleeding because it is a major problem and does not help with precision, surgery time, or postoperative wound healing. The main reason for reoperation and mortality in children who have had tonsillectomies is post-tonsillectomy hemorrhage. Pre-emptive analgesia reduces surgical pain blocking of central sensitization by topical or systemic medications.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 15, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2023
CompletedFirst Submitted
Initial submission to the registry
April 5, 2023
CompletedFirst Posted
Study publicly available on registry
April 18, 2023
CompletedApril 21, 2023
April 1, 2023
14 days
April 5, 2023
April 19, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperative bleeding, pain and postoperative opioid consumption
Postoperative bleeding, pain and postoperative opioid consumption
12 month
Study Arms (2)
Group T
EXPERIMENTALGroup T: received lidocaine (2 %) 2 ml and tranexamic acid 2 ml in each tonsillar bed;
Group N
PLACEBO COMPARATORGroup N (Control group): received 4 ml of normal saline in each tonsillar bed.
Interventions
lidocaine (2 %) 2 ml and tranexamic acid 2 ml in each tonsillar bed
Eligibility Criteria
You may qualify if:
- Male or female child between 4 and 12 years old
- ASA one and two, planned for an elective tonsillectomy
- Patients having 4 or more episodes of tonsillitis in the last year, 5 or more episodes in the previous two years, or 7 episodes in the previous three years.
You may not qualify if:
- Children with diabetes mellitus, problems of the heart, kidneys, or liver 4-Obstructive sleep apnea syndrome 5-blood disorders, or a propensity to hemorrhage 6-patients suspected of an allergy to the drug being administered, and those undergoing concurrent surgery such as an adenoidectomy or tongue tie.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- mohamedlead
- Al-Azhar Universitycollaborator
Study Sites (1)
MEDICIN
Cairo, 11765, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
abdalla mohamed abdalla, MD
AZHAR
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- assissant professor of anesthesia
Study Record Dates
First Submitted
April 5, 2023
First Posted
April 18, 2023
Study Start
May 1, 2022
Primary Completion
May 15, 2022
Study Completion
March 1, 2023
Last Updated
April 21, 2023
Record last verified: 2023-04